Fierce Healthcare February 21, 2018
Leslie Small

If Medicare Advantage encounter data are good enough to be used for calculating payments to insurers, it should be good enough to provide to researchers, argues a new JAMA Viewpoint piece.

Despite concerns about the quality of Medicare Advantage encounter data, it’s long past time to make that information available to researchers who want to study the ever-growing privatized Medicare program.

That’s the argument of a new Viewpoint piece published by the Journal of the American Medical Association, which is largely a reaction to the Centers for Medicare & Medicaid Services’ decision last June to cancel the release of data on MA enrollees’ diagnoses and the services they received.

CMS said at the time that it made that decision...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: CMS, Medicare Advantage
Navigating Medicare Advantage in 2025: Strategies for Success Amid Uncertainty
Medicare Advantage Enrollees Use Less Home Health Care In Their Final Days Than Traditional Medicare Patients
Medicare Advantage insurers ranked by prior authorization denial rates | 2023
Why Yale New Haven is having 'frank conversations' about MA
Medicare Advantage insurers made about 50 million prior authorization determinations in 2023

Share This Article